Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study

Eva Futtrup Maksten,1,2,* Rasmus Rask Kragh Jørgensen,1,2,* Mathilde Selmar Pedersen,1,2 Kirsten Fonager,2,3 Rie Sander Bech,1,2 Ingolf Mølle,4 Andreas Due Ørskov,5 Claudia Schöllkopf,6 Ulrik Malthe Overgaard,6 Gunhild Nynke Thomsen,7 Tarec C El-Galaly,1,2 Marianne Tang Severinsen1,2...

Full description

Bibliographic Details
Main Authors: Maksten EF, Jørgensen RRK, Pedersen MS, Fonager K, Bech RS, Mølle I, Ørskov AD, Schöllkopf C, Overgaard UM, Thomsen GN, El-Galaly TC, Severinsen MT
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Clinical Epidemiology
Subjects:
Online Access:https://www.dovepress.com/work-disability-and-return-to-work-after-treatment-for-acute-lymphobla-peer-reviewed-fulltext-article-CLEP
_version_ 1797262181975195648
author Maksten EF
Jørgensen RRK
Pedersen MS
Fonager K
Bech RS
Mølle I
Ørskov AD
Schöllkopf C
Overgaard UM
Thomsen GN
El-Galaly TC
Severinsen MT
author_facet Maksten EF
Jørgensen RRK
Pedersen MS
Fonager K
Bech RS
Mølle I
Ørskov AD
Schöllkopf C
Overgaard UM
Thomsen GN
El-Galaly TC
Severinsen MT
author_sort Maksten EF
collection DOAJ
description Eva Futtrup Maksten,1,2,* Rasmus Rask Kragh Jørgensen,1,2,* Mathilde Selmar Pedersen,1,2 Kirsten Fonager,2,3 Rie Sander Bech,1,2 Ingolf Mølle,4 Andreas Due Ørskov,5 Claudia Schöllkopf,6 Ulrik Malthe Overgaard,6 Gunhild Nynke Thomsen,7 Tarec C El-Galaly,1,2 Marianne Tang Severinsen1,2 1Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; 2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; 3Department of Social Medicine, Aalborg University Hospital, Aalborg, Denmark; 4Department of Hematology, Aarhus University Hospital, Aarhus, Denmark; 5Department of Hematology, Zealand University Hospital, Roskilde, Denmark; 6Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark; 7Department of Hematology, Odense University Hospital, Odense, Denmark*These authors contributed equally to this workCorrespondence: Eva Futtrup Maksten, Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Sdr. Skovvej 15, Aalborg, 9000, Denmark, Tel +45 97666864, Fax +45 97666323, Email efm@rn.dkPurpose: Most adult patients diagnosed with acute lymphoblastic leukemia (ALL) are below retirement age. The overall survival of patients with ALL has improved with implementation of high intensity pediatric-inspired treatment protocols. However, this treatment comes with a risk of long-term complications, which could affect the ability to work. The aim of this study was to investigate the risk of disability pension (DP) and return to work (RTW) for patients with ALL.Patients and Methods: Patients aged 18– 60 years diagnosed with ALL between 2005 and 2019 were identified in the Danish National Acute Leukemia Registry. Each patient was matched with five comparators from the general population on birth year, sex, and Charlson Comorbidity Index. The Aalen-Johansen estimator was used to calculate the cumulative risk of DP for patients and comparators from index date (defined as 1 year after diagnosis) with competing events (transplantation or relapse, death, retirement pension, or early retirement pension). Differences in cumulative incidences were calculated using Gray’s test. RTW was calculated as proportions one, three, and five years after the index date for patients holding a job before diagnosis.Results: A total of 154 patients with ALL and 770 matched comparators were included. The 5-year cumulative risk of DP was increased fivefold for patients with ALL compared with the general population. RTW was 41.7%, 65.7%, and 60.7% one, three, and five years after the index date, respectively.Conclusion: The risk of DP in patients with ALL increased significantly compared with the general population. Five years after the index date, RTW was 60.7% for patients with ALL.Keywords: acute lymphoblastic leukemia, disability pension, return to work
first_indexed 2024-04-24T23:53:02Z
format Article
id doaj.art-6b0dd65d5946464398b3e60991776ae4
institution Directory Open Access Journal
issn 1179-1349
language English
last_indexed 2024-04-24T23:53:02Z
publishDate 2024-03-01
publisher Dove Medical Press
record_format Article
series Clinical Epidemiology
spelling doaj.art-6b0dd65d5946464398b3e60991776ae42024-03-14T17:13:25ZengDove Medical PressClinical Epidemiology1179-13492024-03-01Volume 1619120291234Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort StudyMaksten EFJørgensen RRKPedersen MSFonager KBech RSMølle IØrskov ADSchöllkopf COvergaard UMThomsen GNEl-Galaly TCSeverinsen MTEva Futtrup Maksten,1,2,* Rasmus Rask Kragh Jørgensen,1,2,* Mathilde Selmar Pedersen,1,2 Kirsten Fonager,2,3 Rie Sander Bech,1,2 Ingolf Mølle,4 Andreas Due Ørskov,5 Claudia Schöllkopf,6 Ulrik Malthe Overgaard,6 Gunhild Nynke Thomsen,7 Tarec C El-Galaly,1,2 Marianne Tang Severinsen1,2 1Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; 2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; 3Department of Social Medicine, Aalborg University Hospital, Aalborg, Denmark; 4Department of Hematology, Aarhus University Hospital, Aarhus, Denmark; 5Department of Hematology, Zealand University Hospital, Roskilde, Denmark; 6Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark; 7Department of Hematology, Odense University Hospital, Odense, Denmark*These authors contributed equally to this workCorrespondence: Eva Futtrup Maksten, Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Sdr. Skovvej 15, Aalborg, 9000, Denmark, Tel +45 97666864, Fax +45 97666323, Email efm@rn.dkPurpose: Most adult patients diagnosed with acute lymphoblastic leukemia (ALL) are below retirement age. The overall survival of patients with ALL has improved with implementation of high intensity pediatric-inspired treatment protocols. However, this treatment comes with a risk of long-term complications, which could affect the ability to work. The aim of this study was to investigate the risk of disability pension (DP) and return to work (RTW) for patients with ALL.Patients and Methods: Patients aged 18– 60 years diagnosed with ALL between 2005 and 2019 were identified in the Danish National Acute Leukemia Registry. Each patient was matched with five comparators from the general population on birth year, sex, and Charlson Comorbidity Index. The Aalen-Johansen estimator was used to calculate the cumulative risk of DP for patients and comparators from index date (defined as 1 year after diagnosis) with competing events (transplantation or relapse, death, retirement pension, or early retirement pension). Differences in cumulative incidences were calculated using Gray’s test. RTW was calculated as proportions one, three, and five years after the index date for patients holding a job before diagnosis.Results: A total of 154 patients with ALL and 770 matched comparators were included. The 5-year cumulative risk of DP was increased fivefold for patients with ALL compared with the general population. RTW was 41.7%, 65.7%, and 60.7% one, three, and five years after the index date, respectively.Conclusion: The risk of DP in patients with ALL increased significantly compared with the general population. Five years after the index date, RTW was 60.7% for patients with ALL.Keywords: acute lymphoblastic leukemia, disability pension, return to workhttps://www.dovepress.com/work-disability-and-return-to-work-after-treatment-for-acute-lymphobla-peer-reviewed-fulltext-article-CLEPacute lymphoblastic leukemiadisability pensionreturn to work
spellingShingle Maksten EF
Jørgensen RRK
Pedersen MS
Fonager K
Bech RS
Mølle I
Ørskov AD
Schöllkopf C
Overgaard UM
Thomsen GN
El-Galaly TC
Severinsen MT
Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study
Clinical Epidemiology
acute lymphoblastic leukemia
disability pension
return to work
title Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study
title_full Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study
title_fullStr Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study
title_full_unstemmed Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study
title_short Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study
title_sort work disability and return to work after treatment for acute lymphoblastic leukemia a danish nationwide cohort study
topic acute lymphoblastic leukemia
disability pension
return to work
url https://www.dovepress.com/work-disability-and-return-to-work-after-treatment-for-acute-lymphobla-peer-reviewed-fulltext-article-CLEP
work_keys_str_mv AT makstenef workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT jørgensenrrk workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT pedersenms workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT fonagerk workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT bechrs workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT møllei workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT ørskovad workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT schollkopfc workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT overgaardum workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT thomsengn workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT elgalalytc workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy
AT severinsenmt workdisabilityandreturntoworkaftertreatmentforacutelymphoblasticleukemiaadanishnationwidecohortstudy